| Authors: |
Munshani S; Department of Pharmacology, Yale School of Medicine, New Haven, CT, USA., Ibrahim EY; Department of Pharmacology, Yale School of Medicine, New Haven, CT, USA., Rodwin RL; Department of Pediatrics (Hematology/Oncology), Yale School of Medicine, New Haven, CT, USA., Ferrucci LM; Department of Chronic Disease Epidemiology and Yale Cancer Center, Yale School of Public Health, New Haven, CT, USA., Blenman K; Department of Medicine (Medical Oncology), Yale School of Medicine, New Haven, CT, USA.; Department of Computer Science, School of Engineering and Applied Science, Yale University, New Haven, CT, USA., Lustberg M; Department of Medicine (Medical Oncology), Yale School of Medicine, New Haven, CT, USA., Ehrlich BE; Department of Pharmacology, Yale School of Medicine, New Haven, CT, USA. |
